Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Arturo Contis-Montes de Oca; Estefanía Rodarte-Valle; Martha Cecilia Rosales-Hernández; Edgar Abarca-Rojano; Saúl Rojas-Hernández; Manuel Jonathan Fragoso-Vázquez; Jessica Elena Mendieta-Wejebe; Ana María Correa-Basurto; Ismael Vázquez-Moctezuma; José Correa-Basurto

ArticleOPEN ACCESS

Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Oncotarget

ISSN: 19492553

0Citations

6Readers

Abstract

This article has been corrected: The correct author list is given below: Arturo Contis-Montes de Oca1,*, Estefanía Rodarte-Valle2,*, Martha Cecilia Rosales-Hernández2, Edgar Abarca-Rojano3, Saúl Rojas-Hernández1, Manuel Jonathan Fragoso-Vázquez4, Jessica Elena Mendieta-Wejebe2, Ana María Correa-Basurto2, Ismael Vázquez-Moctezuma2 and José Correa-Basurto2,5.

Cite

CITATION STYLE

APA

Contis-Montes de Oca, A., Rodarte-Valle, E., Rosales-Hernández, M. C., Abarca-Rojano, E., Rojas-Hernández, S., Fragoso-Vázquez, M. J., … Correa-Basurto, J. (2019, February 1). Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077). Oncotarget. Impact Journals LLC.

Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Abstract

Cite

Register to see more suggestions